We are live on ! Find out more
BCP

BlackBarn Capital Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 55.98%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+55.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$761M
AUM Growth
-$364M
Cap. Flow
-$392M
Cap. Flow %
-51.51%
Top 10 Hldgs %
91.15%
Holding
25
New
4
Increased
10
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$10.2M
2
CIVI
Civitas Resources
CIVI
+$6.81M
3
LW icon
Lamb Weston
LW
+$5.78M
4
AMRX icon
Amneal Pharmaceuticals
AMRX
+$3.22M
5
T icon
AT&T
T
+$2.98M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$10.7M
2
KNF icon
Knife River
KNF
+$9.47M
3
UNH icon
UnitedHealth
UNH
+$3.56M

Sector Composition

Rank Sector Weight
1 Healthcare 18.32%
2 Financials 3.54%
3 Energy 3.03%
4 Communication Services 2.17%
5 Consumer Staples 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$779B
$287M 37.7%
+500,000
New +$276M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$446B
$244M 32.07%
500,000
-750,000
-60% -$355M
ROIV icon
3
Roivant Sciences
ROIV
$25B
$46.2M 6.07%
4,000,000
+900,000
+29% +$10.2M
MOH icon
4
Molina Healthcare
MOH
$10.6B
$20.7M 2.72%
60,000
+7,500
+14% +$2.47M
AMRX icon
5
Amneal Pharmaceuticals
AMRX
$5.73B
$20.1M 2.64%
2,411,612
+411,612
+21% +$3.22M
DHC
6
Diversified Healthcare Trust
DHC
$2.25B
$18.5M 2.43%
4,408,497
+408,497
+10% +$1.38M
T icon
7
AT&T
T
$168B
$16.5M 2.17%
750,000
+150,000
+25% +$2.98M
UNH icon
8
UnitedHealth
UNH
$380B
$15M 1.97%
25,700
-6,300
-20% -$3.56M
BRBS icon
9
Blue Ridge Bankshares
BRBS
$311M
$13.2M 1.73%
4,702,747
CIVI
10
DELISTED
Civitas Resources
CIVI
$12.7M 1.66%
250,000
+110,000
+79% +$6.81M
ELV icon
11
Elevance Health
ELV
$82B
$11.7M 1.54%
22,500
+4,500
+25% +$2.4M
CHRD icon
12
Chord Energy
CHRD
$7.56B
$10.4M 1.37%
80,000
+16,000
+25% +$2.45M
TEVA icon
13
Teva Pharmaceuticals
TEVA
$36.2B
$9.14M 1.2%
506,971
+6,971
+1% +$122K
ABUS icon
14
Arbutus Biopharma
ABUS
$873M
$7.97M 1.05%
2,070,900
BVFL icon
15
BV Financial
BVFL
$185M
$7.37M 0.97%
480,000
PRVA icon
16
Privia Health
PRVA
$3.18B
$7.28M 0.96%
400,000
LW icon
17
Lamb Weston
LW
$7.15B
$5.66M 0.74%
+87,500
New +$5.78M
TCBX icon
18
Third Coast Bancshares
TCBX
$701M
$5.22M 0.69%
194,893
+44,893
+30% +$1.07M
MODV
19
DELISTED
ModivCare
MODV
$1.44M 0.19%
+100,577
New +$2.31M
BCBP icon
20
BCB Bancorp
BCBP
$178M
$1.16M 0.15%
+94,288
New +$1.12M
COIN icon
21
PUT
Coinbase
COIN
$43.9B
-500,000
Closed -$111M
KNF icon
22
Knife River
KNF
$4.42B
-135,000
Closed -$9.47M
NVDA icon
23
PUT
NVIDIA
NVDA
$4.75T
-1,700,000
Closed -$210M
ODD icon
24
PUT
ODDITY Tech
ODD
$755M
-282,700
Closed -$11.1M
RH icon
25
RH
RH
$3.4B
-43,655
Closed -$10.7M

Similar funds

BlackBarn Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, BlackBarn Capital Partners held 25 positions worth $761M, down 32% from $1.13B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

BlackBarn Capital Partners withdrew a net $392M in Q3 2024, closing 5 positions and reducing 2 holdings. Its most notable exit was RH, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 9.7% a quarter earlier, followed by Financials and Energy.

Against the trend, BlackBarn Capital Partners opened a new position in Lamb Weston worth $5.66M.

  • BlackBarn Capital Partners's largest Q3 2024 buy was Lamb Weston: 87,500 shares worth $5.66M.
  • BlackBarn Capital Partners added most to Roivant Sciences in Q3 2024, an estimated $10.2M increase.
  • BlackBarn Capital Partners's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $3.56M.
  • BlackBarn Capital Partners fully exited RH in Q3 2024, selling an estimated $10.7M.
  • BlackBarn Capital Partners's ten largest holdings make up 91% of its $761M portfolio in Q3 2024.
  • BlackBarn Capital Partners opened 4 new positions and closed 5 in Q3 2024.
  • BlackBarn Capital Partners's portfolio value fell 32% quarter-over-quarter to $761M.

Based on BlackBarn Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.